Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 132.26 M

Hims & Hers Health, Inc. EBITDA is USD 132.26 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 6,162.31% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 2.11 M, a -103.83% change year over year.
  • Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -55.19 M, a -37.15% change year over year.
  • Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -87.81 M, a 55.99% change year over year.
  • Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -56.29 M, a -3.04% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)